Global Heparin Market
The Global Heparin Market is expected to grow from USD 9.38 billion in 2021 to USD 10.6 billion in 2027 at a CAGR of 3.2% from 2022-2027.
Heparin, also called as unfractionated heparin (UFH), is a glycosaminoglycan which occurs naturally. It is used as an anticoagulant in medicine (blood thinner). It is chiefly used for the treatment of heart attacks and unstable angina. It is injected into the vein or under the skin. Heparin also used to treat various health issues such as acute coronary syndrome, deep vein thrombosis, pulmonary embolism, and atrial fibrillation, as well as cardiopulmonary bypass and hemofiltration during cardiac surgery. Moreover, heparin is administered in major orthopedic surgeries such as hip and knee replacement.
Market Drivers
The Growing incidence of venous thrombosis and cardiovascular diseases is the key component which drives the growth of The Global Heparin Market. Additionally, implementation of heparin in variety of surgeries such as orthopedic and heart surgeries, and increase in number of patients go through such surgeries further boost the growth of heparin market. Also, the availability of synthetic and semi-synthetic heparin derivative which helps to trat cancer, coagulation and inflammatory diseases is anticipated to impart profitable opportunity for heparin usage. Rise in government support for health infrastructure development and comprehensive R&D activities to grow heparin with improved therapeutic potential and less side effects, drive the growth of heparin market.
Market Restraints
Lots of adverse side effect associated with heparin and presence of variety of coagulant in the market may impede the growth of the heparin market. Increasing concern about deficiency of raw material for the manufacturing of porcine based type of heparin are the elements affecting the growth of the heparin market. At the time of lockdown, there was insufficiency of raw material, that was the biggest challenge for the heparin market.
Market Segmentation
The Global Heparin Market is segmented into Product Type, Application, Distribution Channel, Route of Administration, Source. By Product Type such as Unfractionated Heparin (UFH), Low Molecular Weight Heparin (LMWH), Ultra-Molecular Heparin. By Application such as Venous Thromboembolism, Atrial fibrillation, Renal Impairment, Coronary Artery Disease, Others. By Distribution Channel such as Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies. By Route of Administration such as Intravenous Infusion, Subcutaneous Injection. By Source such as Bovine, Porcine.
Regional Analysis
The Global Heparin Market is segmented into five regions such as North America, Europe, Asia Pacific, Latin America, and MEA. North America influences the market and accounted for largest profit share in 2021 owing to increase in cardiovascular disorders and injuries. Also, rising healthcare expenditure level, and increasing patient awareness in this region are the components that can responsible for the region’s high share. In the Asia Pacific, market is expected to witness rapid growth rate during the forecast period. The increasing geriatric population, large population with chronic disease, and rising economies are some of the primary elements driving the growth of heparin market in this region.
Key Players
Key companies across the Global Heparin Market includes Pfizer Inc., LEO Pharma A/S, Dr. Reddy’s, Laboratories Ltd., GlaxoSmithKline plc, Sanofi, Aspen Holdings, Fresenius SE & Co. KGaA, B. Braun Medical, Inc., Sandoz (Novartis AG)
Market Taxonomy
By Product
By Application
By Distribution Channel
By Route of Administration
By Source
By Region
Global Heparin Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Heparin Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Heparin Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Heparin Market Share Analysis, By Product
5.3 Global Heparin Market Size and Forecast, By Product
5.3.1 Unfractionated Heparin (UFH)
5.3.2 Low Molecular Weight Heparin (LMWH)
5.3.3 Ultra-Molecular Heparin.
6 Global Heparin Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Heparin Market Share Analysis, By Application
6.3 Global Heparin Market Size and Forecast, By Application
6.3. 1 Venous Thromboembolism
6.3.2 Atrial Fibrillation
6.3.3 Renal Impairment
6.3.4 coronary artery disease
6.3.5 Others.
7 Global Heparin Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Heparin Market Share Analysis, By Distribution Channel
7.3 Global Heparin Market Size and Forecast, By Distribution Channel
7.3.1 Hospital Pharmacies
7.3.2 Drug Stores & Retail Pharmacies
7.3.3 Online Pharmacies
8 Global Heparin Market, By Route of Administration
8.1 Y-o-Y Growth Comparison, By Route of Administration
8.2 Global Heparin Market Share Analysis, By Route of Administration
8.3 Global Heparin Market Size and Forecast, By Route of Administration
8.3.1 Intravenous Infusion
8.3.2 Subcutaneous Injection
9 Global Heparin Market, By Source
9.1 Y-o-Y Growth Comparison, By Source
9.2 Global Heparin Market Share Analysis, By Source
9.3 Global Heparin Market Size and Forecast, By Source
9.3.1 Bovine
9.3.2 Porcine
10 Global Heparin Market, By Region
10.1 Global Heparin Market Share Analysis, By Region
10.2 Global Heparin Market Share Analysis, By Region
10.3 Global Heparin Market Size and Forecast, By Region
11 North America Heparin Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 North America Heparin Market Share Analysis, By Product
11.3 North America Heparin Market Size and Forecast, By Application
11.4 North America Heparin Market Size and Forecast, By Distribution Channel
11.5 North America Heparin Market Size and Forecast, By Route of Administration
11.6 North America Heparin Market Size and Forecast, By Source
11.7 North America Heparin Market Size and Forecast, By Country
11.7.1 U.S.
11.7.2 Canada
11.7.3 Mexico
12 Europe Heparin Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Europe Heparin Market Share Analysis, By Product
12.3 Europe Heparin Market Size and Forecast, By Application
12.4 Europe Heparin Market Size and Forecast, By Distribution Channel
12.5 Europe Heparin Market Size and Forecast, By Route of Administration
12.6 Europe Heparin Market Size and Forecast, By Source
12.7 Europe Heparin Market Size and Forecast, By Country
12.7.1 Germany
12.7.2 France
12.7.3 UK
12.7.4. Rest of Europe
13 Asia Pacific Heparin Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Asia Pacific Heparin Market Share Analysis, By Product
13.3 Asia Pacific Heparin Market Size and Forecast, By Application
13.4 Asia Pacific Heparin Market Size and Forecast, By Distribution Channel
13.5 Asia Pacific Heparin Market Size and Forecast, By Route of Administration
13.6 Asia Pacific Heparin Market Size and Forecast, By Source
13.7 Asia Pacific Heparin Market Size and Forecast, By Country
13.7.1 China
13.7.2 Japan
13.7.3 India
13.7.4. Rest of Asia Pacific
14 Latin America Heparin Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Latin America Heparin Market Share Analysis, By Product
14.3 Latin America Heparin Market Size and Forecast, By Application
14.4 Latin America Heparin Market Size and Forecast, By Distribution Channel
14.5 Latin America Heparin Market Size and Forecast, By Route of Administration
14.6 Latin America Heparin Market Size and Forecast, By Source
14.7 Latin America Heparin Market Size and Forecast, Country
14.7.1. Brazil
14.7.2. Rest of Latin America
15 Middle East Heparin Market Analysis and Forecast (2022-2027)
15.1 Introduction
15.2 Middle East Heparin Market Share Analysis, By Product
15.3 Middle East Heparin Market Size and Forecast, By Application
15.4 Middle East Heparin Market Size and Forecast, By Distribution Channel
15.5 Middle East Heparin Market Size and Forecast, By Route of Administration
15.6 Middle East Heparin Market Size and Forecast, By Source
15.7 Middle East Heparin Market Size and Forecast, By Country
15.7.1. Saudi Arabia
15.7.2. UAE
15.7.3. Egypt
15.7.4. Kuwait
15.7.5. South Africa
16 Competitive Analysis
16.1 Competition Dashboard
16.2 Market share Analysis of Top Vendors
16.3 Key Development Strategies
17 Company Profiles
17.1 Pfizer Inc
17.1.1 Overview
17.1.2 Offerings
17.1.3 Key Financials
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2 LEO Pharma A/S
17.2.1 Overview
17.2.2 Offerings
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3 Dr. Reddy’s Laboratories Ltd
17.3.1 Overview
17.3.2 Offerings
17.3.3 Key Financials
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4 GlaxoSmithKline plc
17.4.1 Overview
17.4.2 Offerings
17.4.3 Key Financials
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
17.4.6 Key Strategies
17.5 Sanofi
17.5.1 Overview
17.5.2 Offerings
17.5.3 Key Financials
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6 Aspen Holdings
17.6.1 Overview
17.6.2 Offerings
17.6.3 Key Financials
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7 Fresenius SE & Co. KGaA
17.7.1 Overview
17.7.2 Offerings
17.7.3 Key Financials
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies
17.8 B. Braun Medical, Inc.
17.8.1 Overview
17.8.2 Offerings
17.8.3 Key Financials
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9 Sandoz (Novartis AG)
17.9.1 Overview
17.9.2 Offerings
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
